Concurrent central retinal artery occlusion and branch retinal vein occlusion in giant cell arteritis by Chu, Edward R & Chen, Celia S
© 2010 Chu and Chen, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
Clinical Ophthalmology 2010:4 565–567
Clinical Ophthalmology Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
565
CAse RePORT
open access to scientific and medical research
Open Access Full Text Article
10834
Concurrent central retinal artery occlusion  
and branch retinal vein occlusion in giant  
cell arteritis
edward R Chu 
Celia s Chen
Department of Ophthalmology, 
Flinders Medical Centre and Flinders 
University, Bedford Park, sA, Australia
Correspondence: Celia s Chen 
Department of Ophthalmology, Flinders 
Medical Centre, Flinders Drive, Bedford 
Park, south Australia, 5042, Australia
Tel +61 8 8204 4899
Fax +61 8 8277 0899
email celia.chen@health.sa.gov.au
Abstract: Ophthalmic involvement in giant cell arteritis can manifest in a number of ways. Central 
retinal artery occlusion is one of the common causes of visual loss in giant cell arteritis. On the 
contrary, branch retinal vein occlusion is rarely associated with the latter. We report an 89-year-
old lady with acute left central retinal artery occlusion on a background of progressive decline in 
vision over a 6-month period with a concurrent right branch retinal vein occlusion. Subsequent 
investigation confirmed giant cell arteritis on temporal artery biopsy. This is the first reported 
case of a concurrent central retinal artery occlusion and branch retinal vein occlusion in giant cell 
arteritis, and highlights the various ocular presentations that can occur in giant cell arteritis.
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Case report
An 89-year-old lady presented with an acute painless loss of vision in the left eye 
on a background of progressive decline of vision over a 6-month period. Further 
history revealed a 6-month history of mild headache, lethargy, and jaw claudication, 
which she put down to the ‘flu’. Her pertinent past medical history included con-
trolled hypertension since 1996 with mean arterial pressure of 110 mmHg. She has 
peripheral vascular disease with claudication after walking 100 meters but did not 
require vascular intervention. On examination, her best-corrected visual acuity was 
20/40 OD and hand movement OS. There was a left relative afferent pupillary defect 
associated with recognition of gross color only in the left eye. Neuro-ophthalmic 
examination showed normal extraocular motility and cranial nerves. There was no 
scalp tenderness. Her left temporal artery was prominent and firm to palpate, how-
ever, the pulse was impalpable. Anterior segments revealed bilateral nuclear sclerotic 
cataracts. Fundoscopy of the right eye revealed hemorrhage in the superior temporal 
quadrant suggestive of branch retinal vein occlusion (BRVO) as shown in Figure 1A. 
This was confirmed with fundus fluorescein angiography. The left eye revealed an 
acute central retinal artery occlusion (CRAO) with retinal infarction and cherry red 
spot. Red free photographs of both fundi are seen in Figure 1B. Fundus fluorescein 
angiography of the left eye revealed retinal arterial attenuation from CRAO as well 
as patchy choroidal filling defect with delayed retrograde filling suggesting medial 
posterior ciliary artery occlusion with the CRAO (Figure 2). Investigation into the 
cause of the CRAO revealed an acute rise in inflammatory markers including an 
elevated erythrocyte sedimentation rate of 101 mm/hr. Thrombophilia markers were Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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negative. She was managed with a stat dose of methylpred-
nisolone 1 g intravenously followed by oral prednisolone at 1 
mg/kg. A left temporal artery biopsy was performed within 2 
days and histopathology was consistent with GCA associated 
with intimal hyperplasia and luminal narrowing.
Discussion
To our knowledge, this is the first reported case of concurrent 
CRAO and BRVO in an elderly lady with GCA. Among a wide 
variety of ophthalmic manifestations of GCA, CRAO is the 
second most common cause of GCA-related visual loss after 
Figure 1 A) Colored fundus photograph of the right and left eye. The right eye revealed a superior temporal branch retinal vein occlusion (arrow) showing multiple hemorrhages 
(arrowheads). The left eye showed an acute central retinal artery occlusion (cherry red spot (C) and marked arteriole attenuation with pale retina in comparison to the right eye). 
B) Red free photograph of the corresponding fundus illustrating the site of the branch retinal vein occlusion (arrow) and hemorrhages in the right eye (arrowhead).
Figure 2 Fundus fluorescein angiography of the left eye at (A) 25 seconds, (B) 49 seconds, (C) one minute 56 seconds, and (D) 5 minutes 14 seconds that revealed nasal 
choroidal filling defect (star), delayed retrograde filling (arrow), and arterial attenuation (arrowhead).Clinical Ophthalmology
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anterior ischemic optic neuropathy.1 However, a   relationship 
between retinal vein occlusion and GCA is rare.2
BRVO is associated with certain diseases that include 
hypertension and peripheral vascular disease, which are 
both present as medical co-morbidities of this patient. The 
suggested main mechanism of BRVO is trophic changes in 
the venous endothelium and intima media at the arterio-
venous (AV) crossing.3 Furthermore, the patient’s medical 
co-morbidities are associated with the development of retinal 
artery sclerosis.3 At the AV crossing, the retinal artery and 
vein share one adventitial sheath.3 With the increasing rigidity 
of the arterial wall secondary to sclerotic artery, contraction 
of the adventitial sheath occurs resulting in venous compres-
sion.3 The compressed vein leads to turbulent blood flow 
through the AV crossing, damaging the venous endothelium 
and intimamedia. The combined effects of trophic changes 
and turbulent blood flow can potentially result in thrombus 
formation and subsequent venous occlusion.
The above hemodynamic compromises from BRVO 
can be exacerbated in the presence of GCA. The arteritic 
inflammation in GCA can alter the endothelium and result 
in accelerated atherosclerosis.4 This can contribute to the 
development of venous occlusion by further aggravating an 
already compromised venous environment. As GCA and 
vascular risk factors tend to occur more commonly in the 
elderly, BRVO can be an atypical presentation of GCA in this 
patient. Hence, in patients with retinal vein occlusion with 
no or minimal attributable cause, it has been suggested that 
GCA should be considered in the differential diagnosis.2 In 
conclusion, patients with GCA can present with concurrent 
CRAO and BRVO.
Disclosure
The authors report no conflicts of interest in this work.
References
1.  Kawasaki A, Purvin V. Giant cell arteritis: an updated review. Acta 
Ophthalmol. 2009;87(1):13–32.
2.  Zaldivar RA, Calamia KT, Bolling JP. Retinal vein occlusion in giant 
cell arteritis [abstract]. Invest Ophthalmol Vis Sci. 2004;45:1589.
3.  Rehak J, Rehak M. Branch retinal vein occlusion: pathogenesis, visual 
prognosis and treatment modalities. Curr Eye Res. 2008;33(22): 
111–131.
4.  Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Sanchez-Andrade A, 
Martín J, Gonzalez-Gay MA. Steroid therapy improves endothelial 
function in patients with biopsy-proven giant cell arteritis. J Rheumatol. 
2006;33(1):74–78.